Sign in

CIK 0001731348

  • Large accelerated filer

Tilray Brands, Inc.

Sign in to watch
Ticker
TLRY
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
May 31
Entity type
Operating
EIN
824310622
Phone
+1 519-322-8800
Business address
445 PARK AVENUE, NEW YORK, NY, 10022
Former names
Tilray, Inc.
  1. 4 Open-market sale Director sold 4,400 shares at $10.05 ($44,233)
  2. 4 Open-market sale Director sold 4,812 shares at $10.00 ($48,120)
  3. 4 Open-market sale President and CEO sold 400,000 shares at an average $7.43 ($2,973,568)
  4. 4 Open-market sale President and CEO sold 400,000 shares at $6.04 ($2,415,200)
  5. 4 Open-market sale President and CEO sold 400,000 shares at $5.60 ($2,238,560)
  6. 4 Open-market sale President and CEO sold 400,000 shares at $5.61 ($2,243,160)
  7. 4 Open-market sale President and CEO sold 400,000 shares at $5.83 ($2,331,320)
  8. 4 Option exercise Director acquired 2,188 shares (option exercise)
  9. 4 Shares withheld for taxes Chief Revenue Officer gave up 1,812 shares (to pay taxes)
  10. 4 Conversion President and CEO acquired 8,410,907 shares (conversion)
  11. 4 Option exercise Director acquired 30,696 shares (option exercise)
  12. 4 Open-market sale President and CEO sold 500,000 shares at $4.89 ($2,443,300)
  13. 4 Open-market sale President and CEO sold 500,000 shares at $5.13 ($2,567,050)
  14. 4 Open-market sale President and CEO sold 500,000 shares at $5.01 ($2,504,800)
  15. 4 Shares withheld for taxes Chief Corporate Dev Officer gave up 1,731 shares (to pay taxes)
  16. 4 Open-market sale Director sold 5,000 shares at $6.44 ($32,195)
  17. 4 Option exercise Director acquired 2,187 shares (option exercise)
  18. 4 Option exercise Director acquired 2,187 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 12 of 17 · 334 filings